Cost-Effectiveness of Remdesivir for COVID-19 Treatment: What Are We Missing?

Value Health. 2022 May;25(5):697-698. doi: 10.1016/j.jval.2022.02.002. Epub 2022 Mar 19.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adenosine Monophosphate / analogs & derivatives
  • Adenosine Monophosphate / therapeutic use
  • Alanine / analogs & derivatives
  • Antiviral Agents / therapeutic use
  • COVID-19 Drug Treatment*
  • Cost-Benefit Analysis
  • Humans

Substances

  • Antiviral Agents
  • remdesivir
  • Adenosine Monophosphate
  • Alanine